Review links high-dose IV vitamin C to better trauma outcomes
A BMJ Military Health review found lower death and sepsis rates in trauma patients given high-dose IV vitamin C, but evidence remains limited.
By Priya Raghavan · Science Reporter
3 min read
High-dose intravenous vitamin C was associated with improved outcomes for seriously injured patients in a new evidence review, including lower risks of death and sepsis. The findings could affect trauma care if confirmed, but the researchers said the available evidence is limited and does not yet settle how the treatment should be used.
The review, published in BMJ Military Health, examined six previous studies involving nearly 5,200 trauma patients. The research team was led by Dr. Nandesh Patel of the NHS Academic Department of Military Trauma and Orthopedics in Birmingham, U.K., according to HealthDay.
Patel and colleagues wrote that the review shows “positive but limited evidence” for a possible role for IV vitamin C in treating trauma patients. They reported that high-dose IV vitamin C appeared to reduce mortality and sepsis among people hospitalized after major injuries.
What the review found
According to the research team, boosting vitamin C levels in hospitalized trauma patients was linked to a 28% to 86% reduction in the risk of death across the studies they analyzed. Patients who received IV vitamin C also had lower rates of sepsis, a dangerous immune response to infection.
The review also found signs that vitamin C may shorten recovery time in the hospital. One of the studies included in the analysis found that patients given vitamin C were more than twice as likely to be discharged within a month, the researchers reported.
The team said severe injuries such as broken bones and major wounds can set off complex biological responses. In background notes, the researchers said vitamin C could plausibly help by supporting blood pressure, helping regulate blood flow to tissues and countering harmful free radicals.
The body also uses up vitamin C stores quickly after injury, according to the researchers. That rapid depletion is one reason scientists have studied whether high-dose replacement through an IV could help patients recover after trauma.
Researchers urge caution
The review did not establish a clear treatment protocol. The researchers said the studies generally used vitamin C alongside other therapies, making it difficult to isolate how much benefit came from the vitamin itself.
They also said none of the studies tested the best timing or dose for vitamin C treatment. Those gaps limit firm conclusions about how doctors should use it in trauma care, the team wrote.
Patel’s team said the variation in study results suggests the effects may depend on clinical context and may not apply broadly across all critically ill patients. They described the certainty of the evidence as low because of methodological limits in the underlying research.
Even so, the researchers said small reductions in death, sepsis, organ failure or the need for critical care could justify further trauma-specific research before wider clinical adoption. HealthDay reported that the authors framed the findings as a rationale for additional study rather than a basis for routine use.
This story draws on original reporting from Medical Xpress.